The semaglutide and cagrilintide mix produced superior gains in waist circumference (average reduction of 15-17 cm), blood pressure (systolic BP reduced by 8-10 mmHg), lipid profiles (triglycerides reduced by 20-25%, HDL increased by 10-15%), glycemic control in diabetic participants (HbA1c reduced by 1.5-2.0%), and swelling markers (CRP reduced by 40-50%)
Disclaimer: This list is informational and based on publicly available data, accreditation records, patient reviews, and pharmacy industry knowledge
Accurate measurement is vital for valid data
For optimal data accuracy, utilize your reconstituted solution within a 14-day timeline [verify with brand/source]
About the Author Maryke Louw is a chartered physiotherapist with more than 20 years' experience and a Masters Degree in Sports Injury Management